A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)

NCT05429320 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer
Metastatic Non Small Cell Lung Cancer
Nsclc
NSCLC Stage IV
Minimal Residual Disease
Non Small Cell Lung Cancer Metastatic

Interventions

PROCEDURE: Local ablative therapy
OTHER: Blood collection to assess for ctDNA

Sponsor

Memorial Sloan Kettering Cancer Center